Picture of Incyte logo

INCY Incyte Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Incyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-29694934159832.6
Depreciation
Deferred Taxes
Non-Cash Items191223306224161
Unusual Items
Other Non-Cash Items
Changes in Working Capital-71.7-14.6199-249138
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-125749970496335
Capital Expenditures-187-181-77.8-32.5-86.3
Purchase of Fixed Assets
Other Investing Cash Flow Items-81.6-26.7-0.709-175244
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities-269-208-78.5-208158
Financing Cash Flow Items-37.8-50-59-52.5-62.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities71.76.18-0.794-20-2,022
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-319544894262-1,526